RADICAVA ORS Trademark

Trademark Overview


On Monday, March 22, 2021, a trademark application was filed for RADICAVA ORS with the United States Patent and Trademark Office. The USPTO has given the RADICAVA ORS trademark a serial number of 90594021. The federal status of this trademark filing is REGISTERED as of Tuesday, November 22, 2022. This trademark is owned by Mitsubishi Tanabe Pharma Corporation. The RADICAVA ORS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from the human bodies; neuroprotective medicines; pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS)
radicava ors

General Information


Serial Number90594021
Word MarkRADICAVA ORS
Filing DateMonday, March 22, 2021
Status700 - REGISTERED
Status DateTuesday, November 22, 2022
Registration Number6908091
Registration DateTuesday, November 22, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 30, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from the human bodies; neuroprotective medicines; pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS)

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 25, 2021
Primary Code005
First Use Anywhere DateWednesday, June 15, 2022
First Use In Commerce DateWednesday, June 15, 2022

Trademark Owner History


Party NameMitsubishi Tanabe Pharma Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressOsaka 541-8505
JP

Party NameMitsubishi Tanabe Pharma Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOsaka 541-8505
JP

Party NameMitsubishi Tanabe Pharma Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka 541-8505
JP

Trademark Events


Event DateEvent Description
Tuesday, November 22, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 22, 2022REGISTERED-PRINCIPAL REGISTER
Saturday, October 15, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, October 14, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 21, 2022ASSIGNED TO EXAMINER
Saturday, August 6, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 20, 2022USE AMENDMENT FILED
Saturday, August 6, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 20, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, January 25, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 30, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 30, 2021PUBLISHED FOR OPPOSITION
Wednesday, November 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 26, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 26, 2021ASSIGNED TO EXAMINER
Friday, June 25, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 25, 2021NEW APPLICATION ENTERED IN TRAM